Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in MRNA — Moderna, Inc.

CIK 70858 CHARLOTTE, NC
Back to MRNA Full portfolio

Position in MRNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$98,719,817
+$48,612,732 QoQ
Shares Held
1,409,679
+42.9% QoQ
Ownership
0.353%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 777 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$15,743,385
PutShares
609,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. MRNA ranks #23 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in MRNA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $98,719,817 1,409,679
2026-03-31 $50,107,085 986,360
2025-12-31 $40,544,441 1,374,854
2025-09-30 $42,543,839 1,647,071
2025-09-30 $15,743,385 609,500
2025-06-30 $49,091,132 1,779,309
2025-03-31 $27,367,245 965,335
2024-12-31 $31,012,897 745,861
2024-12-31 $2,079,000 50,000
2024-09-30 $71,392,680 1,068,273
2024-09-30 $3,154,376 47,200
2024-06-30 $117,307,184 987,850
2024-06-30 $19,135,375 161,140
2024-06-30 $7,077,500 59,600
2024-03-31 $3,079,584 28,900
2024-03-31 $18,999,648 178,300
2024-03-31 $97,804,494 917,835
2023-12-31 $616,590 6,200
2023-12-31 $75,392,941 758,099
2023-12-31 $2,028,780 20,400
2023-09-30 $104,783,880 1,014,463
2023-09-30 $7,354,248 71,200
2023-09-30 $7,819,053 75,700
2023-06-30 $2,539,350 20,900
2023-06-30 $7,435,800 61,200
2023-06-30 $95,611,385 786,925
2023-03-31 $147,328,829 959,297
2023-03-31 $81,504,906 530,700
2023-03-31 $31,898,566 207,700
2022-12-31 $155,999,970 868,500
2022-12-31 $105,209,538 585,734
2022-12-31 $112,460,082 626,100
2022-09-30 $100,571,625 850,500
2022-09-30 $127,343,425 1,076,900
2022-09-30 $125,116,538 1,058,068
2022-06-30 $119,842,005 838,936
2022-06-30 $6,585,385 46,100
2022-06-30 $207,118,215 1,449,900
2022-03-31 $243,459,705 1,413,327
2022-03-31 $131,796,126 765,100
2022-03-31 $279,474,624 1,622,400
2021-12-31 $292,350,787 1,151,078
2021-12-31 $186,802,290 735,500
2021-12-31 $642,391,614 2,529,300
2021-09-30 $1,051,668,436 2,732,600
2021-09-30 $602,806,218 1,566,300
2021-09-30 $307,523,150 799,052
2021-06-30 $636,936,788 2,710,600
2021-06-30 $457,647,048 1,947,600
2021-06-30 $162,261,440 690,533

Report a Problem

Category
Description
Email (optional, for follow-up)